216 related articles for article (PubMed ID: 11146051)
1. M100,907, a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex.
Pehek EA; McFarlane HG; Maguschak K; Price B; Pluto CP
Brain Res; 2001 Jan; 888(1):51-59. PubMed ID: 11146051
[TBL] [Abstract][Full Text] [Related]
2. 5-HT(2A) receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner.
Liégeois JF; Ichikawa J; Meltzer HY
Brain Res; 2002 Aug; 947(2):157-65. PubMed ID: 12176156
[TBL] [Abstract][Full Text] [Related]
3. 5-HT(1A) and 5-HT(2A) receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex.
Ichikawa J; Dai J; Meltzer HY
Brain Res; 2002 Jun; 939(1-2):34-42. PubMed ID: 12020849
[TBL] [Abstract][Full Text] [Related]
4. 5-HT 2A receptor stimulation by DOI, a 5-HT 2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Kuroki T; Meltzer HY; Ichikawa J
Brain Res; 2003 May; 972(1-2):216-21. PubMed ID: 12711095
[TBL] [Abstract][Full Text] [Related]
5. SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Bonaccorso S; Meltzer HY; Li Z; Dai J; Alboszta AR; Ichikawa J
Neuropsychopharmacology; 2002 Sep; 27(3):430-41. PubMed ID: 12225700
[TBL] [Abstract][Full Text] [Related]
6. DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release.
Ichikawa J; Dai J; Meltzer HY
Brain Res; 2001 Jul; 907(1-2):151-5. PubMed ID: 11430898
[TBL] [Abstract][Full Text] [Related]
7. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Li Z; Ichikawa J; Huang M; Prus AJ; Dai J; Meltzer HY
Psychopharmacology (Berl); 2005 Dec; 183(2):144-53. PubMed ID: 16220333
[TBL] [Abstract][Full Text] [Related]
8. Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism.
Martín-Ruiz R; Puig MV; Celada P; Shapiro DA; Roth BL; Mengod G; Artigas F
J Neurosci; 2001 Dec; 21(24):9856-66. PubMed ID: 11739593
[TBL] [Abstract][Full Text] [Related]
9. Involvement of 5-HT2A receptor and α2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow.
Frånberg O; Marcus MM; Svensson TH
Synapse; 2012 Jul; 66(7):650-60. PubMed ID: 22362425
[TBL] [Abstract][Full Text] [Related]
10. In vitro autoradiography of serotonin 5-HT(2A/2C) receptor-activated G protein: guanosine-5'-(gamma-[(35)S]thio)triphosphate binding in rat brain.
Adlersberg M; Arango V; Hsiung S; Mann JJ; Underwood MD; Liu K; Kassir SA; Ruggiero DA; Tamir H
J Neurosci Res; 2000 Sep; 61(6):674-85. PubMed ID: 10972964
[TBL] [Abstract][Full Text] [Related]
11. The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity.
Bortolozzi A; Díaz-Mataix L; Scorza MC; Celada P; Artigas F
J Neurochem; 2005 Dec; 95(6):1597-607. PubMed ID: 16277612
[TBL] [Abstract][Full Text] [Related]
12. Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats.
Gobert A; Millan MJ
Neuropharmacology; 1999 Feb; 38(2):315-7. PubMed ID: 10218874
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex.
Pehek EA; Nocjar C; Roth BL; Byrd TA; Mabrouk OS
Neuropsychopharmacology; 2006 Feb; 31(2):265-77. PubMed ID: 15999145
[TBL] [Abstract][Full Text] [Related]
14. Lithium differs from anticonvulsant mood stabilizers in prefrontal cortical and accumbal dopamine release: role of 5-HT(1A) receptor agonism.
Ichikawa J; Dai J; Meltzer HY
Brain Res; 2005 Jul; 1049(2):182-90. PubMed ID: 15936730
[TBL] [Abstract][Full Text] [Related]
15. The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats.
Scruggs JL; Schmidt D; Deutch AY
Neurosci Lett; 2003 Aug; 346(3):137-40. PubMed ID: 12853103
[TBL] [Abstract][Full Text] [Related]
16. In vivo modulation of 5-hydroxytryptamine release in mouse prefrontal cortex by local 5-HT(2A) receptors: effect of antipsychotic drugs.
Bortolozzi A; Amargós-Bosch M; Adell A; Díaz-Mataix L; Serrats J; Pons S; Artigas F
Eur J Neurosci; 2003 Sep; 18(5):1235-46. PubMed ID: 12956722
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of 5-hydroxytryptamine (5-HT(2C) ) receptors in the ventrotegmental area inhibits stress-induced but not basal dopamine release in the rat prefrontal cortex.
Pozzi L; Acconcia S; Ceglia I; Invernizzi RW; Samanin R
J Neurochem; 2002 Jul; 82(1):93-100. PubMed ID: 12091469
[TBL] [Abstract][Full Text] [Related]
18. 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release.
Ichikawa J; Ishii H; Bonaccorso S; Fowler WL; O'Laughlin IA; Meltzer HY
J Neurochem; 2001 Mar; 76(5):1521-31. PubMed ID: 11238736
[TBL] [Abstract][Full Text] [Related]
19. The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.
Ichikawa J; Meltzer HY
Brain Res; 2000 Mar; 858(2):252-63. PubMed ID: 10708676
[TBL] [Abstract][Full Text] [Related]
20. Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism.
Ichikawa J; Li Z; Dai J; Meltzer HY
Brain Res; 2002 Nov; 956(2):349-57. PubMed ID: 12445705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
